Association of antiphospholipid antibodies with retinalvascular disease in systemic lupus erythematosus*

https://doi.org/10.1016/S0049-0172(99)80017-1Get rights and content

Abstract

Objectives:

To study the prevalence and characteristics of retinal vasculardisease in patients with systemic lupus erythematosus (SLE) and to analyze their relationship with antiphospholipid antibodies (aft) and other serological markers.

Patients and Methods:

Eighty-two consecutive patients (77 women and 5 men; mean age, 36 years) were studied. All patients fulfilled the 1982 revised criteria of the American College of Rheumatology for the classification of SLE. Ophthalmologic examination included assessment of best corrected visual acuity, tonometry, slit-lamp biomicroscopy, and fundus examination. Serologic studies included determination of anticardiolipin antibodies (aCL) (ELISA), lupus anticoagulant (LA) (coagulation tests), antinuclear antibodies (indirect immunofluorescence), anti-DNA (Farr's test), and anti-ENA antibodies (counterimmunoelectrophoresis).

Results:

Retinal vascular disease was detected in 13 (15%) of 82 SLE patients. The retinal lesions consisted of retinal vascular occlusions in six patients (five arterial and one venous), cotton-wool spots in three, optic disc edema in three, retinal hemorrhages in three, and ischemic optic neuropathy in one. Antiphospholipid antibodies were detected in 10 (77%) of these 13 patients: nine had aCL and two had the LA. When compared with patients without retinal vascular disease, patients with retinopathy had a higher prevalence of aft (77% v 29%, P = .005).

Conclusions:

Retinal vascular disease is frequent in patients with SLE. Thepresence of aPL is associated with a higher prevalence of retinal abnormalities in SLE patients.

References (20)

  • HueyC. et al.

    Discoid lupus erythematosus of the eyelids

    Ophthalmology

    (1983)
  • LevineS.R. et al.

    Visual symptoms with the presence of lupus anticoagulant

    Ophthalmology

    (1988)
  • KleinerR.C. et al.

    Vaso-occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy)

    Ophthalmology

    (1989)
  • CerveraR. et al.

    Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1000 patients

    Medicine (Baltimore)

    (1993)
  • HackettE.R. et al.

    Optic neuritis in systemic lupus erythematosus

    Arch Neurol

    (1974)
  • KlinkhoffA.V. et al.

    Retinopathy in systemic lupus erythematosus: relationship to disease activity

    Arthritis Rheum

    (1986)
  • RavelliA. et al.

    Severe retinopathy in systemic lupus erythematosus associated with IgG anticardiolipin antibodies

    Acta Paediatr

    (1993)
  • JabsD.A. et al.

    Optic neuropathy in systemic lupus erythematosus

    Arch Ophthalmol

    (1986)
  • AshersonR.A. et al.

    “Primary,” “secondary” and other variants of the antiphospholipid syndrome

    Lupus

    (1994)
  • DunnJ.P. et al.

    Antiphospolipid antibodies and retinal vascular disease

    Lupus

    (1996)
There are more references available in the full text version of this article.

Cited by (77)

  • Retinal vasculitis: A framework and proposal for a classification system

    2021, Survey of Ophthalmology
    Citation Excerpt :

    Notably, patients do not usually have an associated anterior uveitis or vitritis. Patients with SLE who have positive antiphospholipid (APL) antibodies are at the highest risk of developing retinal vascular occlusions and retinal ischemia, specifically frosted branch angiitis.12,80 Contrast it to the more common features of lupus retinopathy outlined previously; however, those with APL antibodies present as an occlusive retinopathy, with severe ischemia and vitreous hemorrhage, more consistent with a thrombotic microangiopathy.68

  • Ocular manifestations in Egyptian systemic lupus erythematosus patients and their relation with disease activity and anti-phospholipid antibodies

    2018, Egyptian Rheumatologist
    Citation Excerpt :

    Tolba et al., [25] in their work on 30 active SLE patients, 12 (40%) had retinopathy and SLEDAI score significantly correlated. A large percentage of SLE patients with retinal vasculitis have concomitant aPL antibodies including ACL and LAC [26] and presence of those antibodies are associated with more severe retinopathy and vascular occlusion [27]. Our study showed that SLE patients with ocular affection had significantly higher serum levels of ACL IgM and LAC and consumed complement than those without.

  • The role of ophthalmic imaging in central nervous system degeneration in systemic lupus erythematosus

    2018, Autoimmunity Reviews
    Citation Excerpt :

    Retinal vasculitis, affecting both veins and arterioles, is a much rarer presentation with a significantly worse prognosis than microangiopathy. The finding of retinal vasculitis correlates with anti-phospholipid syndrome as well as with the presence of CNS vasculitis [56,66]. Histopathologic specimens show fibrinoid change with thrombus formation without a true arteritis [67].

View all citing articles on Scopus
*

Supported in part by FISS grant 96/050080.

View full text